O'Rourke & Company’s CVS Health CVS Stock Holding History

O'Rourke & Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,624	Closed	-$245K	–	131
2022 Q4	$245K	Buy	+2,624	New	+$253K	0.19%	114

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

O'Rourke & Company's CVS Position: Q1 2023 in Review

O'Rourke & Company sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,624 shares — an estimated $245K sold.

O'Rourke & Company first reported a position in CVS in Q4 2022 and held it in 1 quarter. The position peaked at $245K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

O'Rourke & Company reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
O'Rourke & Company sold 2,624 CVS Health shares in Q1 2023, an estimated $245K.
O'Rourke & Company first reported a position in CVS Health in Q4 2022 and held it in 1 quarter.
O'Rourke & Company's CVS Health position peaked at $245K in Q4 2022.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on O'Rourke & Company's 13F filing for Q1 2023, filed 12 May 2023.